Multi‐modal models using fMRI , urine and serum biomarkers for classification and risk prognosis in diabetic kidney disease

Documenti analoghi

• Developments in albuminuria testing: A key biomarker for detection, prognosis and surveillance of kidney and cardiovascular disease—A practical update for clinicians
  di: Jelle M. Beernink, et al.
  Pubblicazione: (2025)
• Unveiling urinary diagnostic biomarkers for diabetic kidney disease using metabolomics and machine learning approaches
  di: Yuan Sun, et al.
  Pubblicazione: (2025)
• Neural pathways to bariatric success: What explainable AI reveals that conventional fMRI methods may miss
  di: Adrian Falkowski, et al.
  Pubblicazione: (2025)
• Diabetic kidney disease, biomarkers, and finerenone
  di: Ashish Verma, et al.
  Pubblicazione: (2026)
• Exploring the link between inflammation and brain function after metabolic‐bariatric surgery: A year‐long fMRI study
  di: Magdalena Szwed, et al.
  Pubblicazione: (2025)